Global pharmaceutical giant Pfizer has successfully defended the patent for its sedative drug Precedex against a validity challenge, a big win for the drug maker after a US court found last year that its patents for a ready-to-use version of the drug were invalid for obviousness.
Judge pauses ASIC case against ANZ over $2.5B share placement
Competing law firms agree to join forces in BHP class action
Judge crushes Monster Energy’s opposition to monster wheel trade marks
Investors can’t revive class action over Octaviar collapse
Law firms should air their gender pay gap ‘dirty laundry’, Herbert Smith Freehills boss says
Hundreds of privileged advice docs accidentally disclosed in Radio Rentals class action
Grand Theft Auto modder confident of defence in Take-Two copyright case
Funder can’t keep $2.2M of JustKapital’s Provident settlement cut in court
JustKapital has defeated a bid by funder Litman Holdings to keep $2.2 million remaining from its cut of a $44.25 million settlement in two class actions against the trustees of failed debenture issuer Provident Capital locked down in court until the resolution of a separate dispute between the two funders.
Quintis shareholders can choose which of two class actions is a better bet
Shareholders of troubled sandalwood producer Quintis who are eligible group members in two consolidated class actions against the company can bet on which of the two cases will give them the best returns, if any, and the Federal Court has appointed an independent lawyer to help them make the choice.